Novozymes A/S (OTCMKTS:NVZMY) Shares Gap Up – What’s Next?

Shares of Novozymes A/S (OTCMKTS:NVZMYGet Free Report) gapped up prior to trading on Friday . The stock had previously closed at $59.46, but opened at $64.49. Novozymes A/S shares last traded at $64.71, with a volume of 788 shares trading hands.

Analyst Ratings Changes

Separately, Zacks Research downgraded Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Novozymes A/S has a consensus rating of “Buy”.

Check Out Our Latest Report on NVZMY

Novozymes A/S Price Performance

The firm has a fifty day moving average price of $62.09 and a two-hundred day moving average price of $66.26. The company has a quick ratio of 1.07, a current ratio of 1.75 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $29.96 billion, a P/E ratio of 37.63, a P/E/G ratio of 1.15 and a beta of 0.96.

Novozymes A/S Cuts Dividend

The business also recently announced a dividend, which was paid on Thursday, September 11th. Shareholders of record on Wednesday, September 3rd were given a $0.1856 dividend. This represents a yield of 88.0%. The ex-dividend date of this dividend was Tuesday, September 2nd. Novozymes A/S’s payout ratio is 21.76%.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Read More

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.